Research Article Open Access Double-Blind Peer Review

CEREBROVASCULAR ACCIDENT MANAGEMENT IN ICU: PHARMACOLOGICAL INNOVATIONS AT COCODY UNIVERSITY HOSPITAL

Marie-Louise T. Gbo
Published 28 June 2024
Vol. 1, No. 1 (2024)
pp. 49-60
CC BY 4.0
  1. 1
    Marie-Louise T. Gbo
    Pharmacology Laboratory, UFR Pharmaceutical Sciences, FHB University, Abidjan, Ivory Coast,
    CI

A cerebrovascular accident (CVA), commonly known as a stroke, presents a critical medical emergency characterized by the sudden disruption of blood flow to the brain, leading to neurological damage. This condition, if not promptly addressed within a narrow therapeutic window of 24 hours, can have grave consequences, ranging from death to irreversible impairment of brain function. Hepburn et al. (2018) highlight the severity of CVAs and underscore the urgent need for timely intervention to mitigate their debilitating effects. This abstract underscores the urgency and gravity of cerebrovascular accidents, emphasizing the critical importance of swift and effective intervention to prevent adverse outcomes. The 24-hour window following a CVA represents a crucial period during which medical interventions can significantly influence patient prognosis and outcomes. By providing timely and appropriate treatment, healthcare professionals can minimize neurological damage and improve patient survival and quality of life.

JournalPharmacology, Alternative Medicine, and Healthcare Journal
ISSN3065-064X
Volume / IssueVol. 1, No. 1 (2024)
Pages49-60
Published28 June 2024
Access Open Access
LicenseCC BY 4.0 — reuse with attribution
PublisherKeith Publications
Gbo, M. (2024). CEREBROVASCULAR ACCIDENT MANAGEMENT IN ICU: PHARMACOLOGICAL INNOVATIONS AT COCODY UNIVERSITY HOSPITAL. Pharmacology, Alternative Medicine, and Healthcare Journal, Vol. 1 No. 1, pp. 49-60

 Submit Your Research to Pharmacology, Alternative Medicine, and Healthcare Journal

We invite original research articles, review papers, and case studies. Benefit from rigorous double-blind peer review, rapid decision within 4–8 weeks, DOI for every article, and worldwide open-access distribution.